Beyond Air Files Proxy Statement for Annual Meeting
Ticker: XAIR · Form: DEF 14A · Filed: May 5, 2025 · CIK: 1641631
| Field | Detail |
|---|---|
| Company | Beyond Air, Inc. (XAIR) |
| Form Type | DEF 14A |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Beyond Air proxy filed. Vote on directors & auditors.
AI Summary
Beyond Air, Inc. filed its definitive proxy statement on May 5, 2025, for its annual meeting. The filing details executive compensation, board nominations, and other corporate governance matters. Key proposals include the election of directors and the ratification of the independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and governance, impacting the company's strategic direction.
Risk Assessment
Risk Level: low — This is a standard proxy filing for an annual meeting, not indicating immediate financial distress or significant new risks.
Key Players & Entities
- Beyond Air, Inc. (company) — Registrant
- AIT Therapeutics, Inc. (company) — Former Company Name
- KokiCare, Inc. (company) — Former Company Name
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Beyond Air, Inc. for its annual meeting of shareholders, outlining proposals and information for voting.
When was this filing submitted?
The filing was submitted on May 5, 2025.
What is the company's primary business classification?
Beyond Air, Inc. is classified under SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].
What are some of the former names of Beyond Air, Inc.?
Beyond Air, Inc. was formerly known as AIT Therapeutics, Inc. (name changed January 17, 2017) and KokiCare, Inc. (name changed May 7, 2015).
Where is Beyond Air, Inc. headquartered?
The company's business and mailing address is 900 Stewart Avenue, Suite 301, Garden City, NY 11530.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 5, 2025 regarding Beyond Air, Inc. (XAIR).